Filed: 8/13/2026ACC: 0001011438-26-000516
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 110 equity positions with a total reported market value of $2.21B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
110
Positions
$2.21B
Total AUM (reported)
123.08M
Total Shares
Allocation by class
COM$1.09B49.2%
COM NEW$407.92M18.4%
SHS$222.03M10.0%
COM SHS$99.00M4.5%
SPONSORED ADS$88.09M4.0%
COM PAR $.01$69.30M3.1%
ORD SHS$51.16M2.3%
Portfolio Concentration
Top 3$377.28M17.1%
4–10$520.17M23.5%
11–25$570.67M25.8%
Rest$744.37M33.6%
Top 3 weight
17.1%
Top 10 weight
40.6%
Voting Authority Distribution
Total shares with voting rights: 123.08M
Sole
Full voting authority
123.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole110
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings110
Rows:
ROIVANT SCIENCES LTD
SOLEShares3.75M
TypeSH
Market value$132.71M
6.00%
Sole
3.75M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares987K
TypeSH
Market value$131.00M
5.92%
Sole
987K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares1.28M
TypeSH
Market value$113.56M
5.13%
Sole
1.28M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.59M
TypeSH
Market value$96.27M
4.35%
Sole
1.59M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares5.25M
TypeSH
Market value$96.18M
4.35%
Sole
5.25M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1.38M
TypeSH
Market value$72.04M
3.26%
Sole
1.38M
Shared
0.00
None
0.00
INSMED INC
SOLEShares650K
TypeSH
Market value$69.30M
3.13%
Sole
650K
Shared
0.00
None
0.00
MODERNA INC
SOLEShares975K
TypeSH
Market value$68.28M
3.09%
Sole
975K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares185K
TypeSH
Market value$61.94M
2.80%
Sole
185K
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares590K
TypeSH
Market value$56.15M
2.54%
Sole
590K
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares826.11K
TypeSH
Market value$55.76M
2.52%
Sole
826.11K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares2.90M
TypeSH
Market value$53.59M
2.42%
Sole
2.90M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares550K
TypeSH
Market value$46.85M
2.12%
Sole
550K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares250K
TypeSH
Market value$46.82M
2.12%
Sole
250K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares330K
TypeSH
Market value$43.98M
1.99%
Sole
330K
Shared
0.00
None
0.00
FIRST TRACKS BIOTHERAPEUTICS
SOLEShares2.03M
TypeSH
Market value$40.88M
1.85%
Sole
2.03M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares400K
TypeSH
Market value$38.99M
1.76%
Sole
400K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares1.17M
TypeSH
Market value$38.93M
1.76%
Sole
1.17M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares275K
TypeSH
Market value$33.96M
1.54%
Sole
275K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares1.80M
TypeSH
Market value$33.57M
1.52%
Sole
1.80M
Shared
0.00
None
0.00
ARK ETF TR
SOLEShares750K
TypeSH
Market value$31.55M
1.43%
Sole
750K
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares10.14M
TypeSH
Market value$27.29M
1.23%
Sole
10.14M
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares5.81M
TypeSH
Market value$27.03M
1.22%
Sole
5.81M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares700K
TypeSH
Market value$26.05M
1.18%
Sole
700K
Shared
0.00
None
0.00
BELITE BIO INC
SOLEShares165K
TypeSH
Market value$25.41M
1.15%
Sole
165K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 3.75M | SH | $132.71M 6.00% | 3.75M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 987K | SH | $131.00M 5.92% | 987K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 1.28M | SH | $113.56M 5.13% | 1.28M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.59M | SH | $96.27M 4.35% | 1.59M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 5.25M | SH | $96.18M 4.35% | 5.25M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 1.38M | SH | $72.04M 3.26% | 1.38M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 650K | SH | $69.30M 3.13% | 650K | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 975K | SH | $68.28M 3.09% | 975K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 185K | SH | $61.94M 2.80% | 185K | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 590K | SH | $56.15M 2.54% | 590K | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 826.11K | SH | $55.76M 2.52% | 826.11K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 2.90M | SH | $53.59M 2.42% | 2.90M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 550K | SH | $46.85M 2.12% | 550K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 250K | SH | $46.82M 2.12% | 250K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 330K | SH | $43.98M 1.99% | 330K | 0.00 | 0.00 |
FIRST TRACKS BIOTHERAPEUTICSSOLE | ORD SHS | 2.03M | SH | $40.88M 1.85% | 2.03M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 400K | SH | $38.99M 1.76% | 400K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM SHS | 1.17M | SH | $38.93M 1.76% | 1.17M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 275K | SH | $33.96M 1.54% | 275K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 1.80M | SH | $33.57M 1.52% | 1.80M | 0.00 | 0.00 |
ARK ETF TRSOLE | GENOMIC REV ETF | 750K | SH | $31.55M 1.43% | 750K | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 10.14M | SH | $27.29M 1.23% | 10.14M | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 5.81M | SH | $27.03M 1.22% | 5.81M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 700K | SH | $26.05M 1.18% | 700K | 0.00 | 0.00 |
BELITE BIO INCSOLE | SPONSORED ADS | 165K | SH | $25.41M 1.15% | 165K | 0.00 | 0.00 |
Page 1 of 5
…